| 1461 |
AMK INJECTION 1.2 G |
AMOXICILLIN 1 G, CLAVULANIC ACID 200 MG |
POWDER FOR INJECTION |
VIAL |
TREATMENT OF UPPER RESPIRATORY AND LOWER TRACT INFECTIONS, GENITO-URINARY TRACT INFECTION, SKIN AND SOFT TISSUE INFECTION, BONE AND JOINT INFECTIONS |
NULL |
LAO INTER PHARMA CO.,LTD |
NORTH CHINA PHARMACEUTICAL CO., LTD |
CHINA |
CERTIFICATE RELEASED |
04 I 4412/18 |
18-AUG-2023 |
17-AUG-2026 |
View |
| 1462 |
AMOXY RX 500 |
AMOXICILLIN TRIHYDRATE 573.87 MG EQ.TO AMOXICILLIN 500 MG |
CAPSULE |
ALU-PVC BLISTER |
FOR THE TREATMENT OF INFECTIONS CAUSED BY SUSCEPTIBLE GRAM NEGATIVE BACTERIA(E.G. HAEMOPHILUS INFLUENZAE, ESCHERICHIA COLI, PROTEUS MIRABILIS, SALMONELLA), FOR THE TREATMENT OF INFECTION CAUSED BY SUSCEPTIBLE GRAM POSITIVE BACTERIA (E.G. STREPTOCOCCUS PNEUMONIAE, ENTEROCOCCI, LISTERIA) |
NULL |
LAO INTER PHARMA CO.,LTD |
R X MANUFACTURING CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
05 I 5108/21 |
07-FEB-2025 |
06-FEB-2030 |
View |
| 1463 |
ANALGIC-500 |
MEFENAMIC ACID 500 MG |
FILM COATED TABLET |
PVC-ALU BLISTER |
SYMPTOMATIC RELIEF OF RHEUMATOID ARTHRITIS, OSTEOARTHRITIS AND PAIN INCLUDING MUSCULAR, TRAUMATIC AND DENTAL PAIN, HEADACHE OF MOST ETIOLOGY, POST-OPERATIVE AND POST PARTUM PAIN. PRIMARY DYSMENORRHEA, MENORRHAGIA DUE TO DYSFUNCTION CAUSES AND PRESENCE OF AN IUD WHEN OTHER PELVIC PATHOLOGY HAS BEEN RULED OUT |
NULL |
LAO INTER PHARMA CO.,LTD |
T MAN PHARMA COMPANY LIMITED |
THAILAND |
CERTIFICATE RELEASED |
09 I 5142/21 |
10-FEB-2025 |
09-FEB-2030 |
View |
| 1464 |
CEFIGET 100 MG/5 ML |
CEFIXIME ( AS CEFIXIME TRIHYDRATE ) 100 MG/ 5ML |
POWDER FOR SUSPENSION |
BOTTLE |
CEFIGET ( CEFIXIME ) IS INDICATED IN THE TREATMENT OF THE FOLLOWING INFECTIONS WHEN CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICROORGANISMS: UNCOMPLICATED URINARY TRACT INFECTIONS, OTITIS MEDIA, PHARYNGITIS AND TONSILITIS, ACUTE BRONCHITIS AND ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS, UNCOMPLICATED GONORRHEA. |
NULL |
LAO INTER PHARMA CO.,LTD |
OPAL LABORATORIES (PVT.) LIMITED. |
PAKISTAN |
CERTIFICATE RELEASED |
10 I 3562/11 |
10-Feb-2023 |
09-Feb-2026 |
View |
| 1465 |
CEFIGET 400 MG |
CEFIXIME COMPACTED ( AS CEFIXIME TRIHYDRATE) 400 MG |
CAPSULE |
ALU-ALU |
CEFIGET ( CEFIXIME ) IS INDICATED IN THE TREATMENT OF THE FOLLOWING INFECTIONS WHEN CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICROORGANISMS: UNCOMPLICATED URINARY TRACT INFECTIONS, OTITIS MEDIA, PHARYNGITIS AND TONSILITIS, ACUTE BRONCHITIS AND ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS, UNCOMPLICATED GONORRHEA. |
NULL |
LAO INTER PHARMA CO.,LTD |
OPAL LABORATORIES (PVT.) LIMITED. |
PAKISTAN |
CERTIFICATE RELEASED |
10 I 3572/11 |
10-Feb-2023 |
09-Feb-2026 |
View |
| 1466 |
CEFIGET DS 200MG/5ML |
CEFIXIME ( AS CEFIXIME TRIHYDRATE) 200 MG/5ML |
POWDER FOR SUSPENSION |
Bottle |
CEFIGET ( CEFIXIME ) IS INDICATED IN THE TREATMENT OF THE FOLLOWING INFECTIONS WHEN CAUSED BY SUSCEPTIBLE STRAINS OF THE DESIGNATED MICROORGANISMS: UNCOMPLICATED URINARY TRACT INFECTIONS, OTITIS MEDIA, PHARYNGITIS AND TONSILITIS, ACUTE BRONCHITIS AND ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS, UNCOMPLICATED GONORRHEA. |
NULL |
LAO INTER PHARMA CO.,LTD |
OPAL LABORATORIES (PVT.) LIMITED. |
PAKISTAN |
CERTIFICATE RELEASED |
10 I 3571/11 |
10-Feb-2023 |
09-Feb-2026 |
View |
| 1467 |
CLARITEK 125MG/5ML |
CLARITHROMYCIN USP 125MG/5ML |
GRANULES FOR ORAL SUSPENSION |
BOTTLE |
TREATMENT OF INFECTIONS DUE TO SUSCEPTIBLE ORGANISMS SUCH INFECTIONS INCLUDE: LOWER RESPIRATORY TRACT INFECTIONS (E.G., BRONCHITIS, PNEUMONIA), UPPER RESPIRATORY TRACT INFECTION, ACUTE OTITIS MEDIA IN CHILDREN, SKIN AND SOFT TISSUE INFECTION. |
NULL |
LAO INTER PHARMA CO.,LTD |
GETZ PHARMA (PRIVATE) LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 2914/07 |
10-Feb-2023 |
09-Feb-2026 |
View |
| 1468 |
CLARITEK DROPS 125MG/5ML |
CLARITHROMYCIN GRANULES 125MG/5ML |
GRANULES FOR ORAL SUSPENSION |
BOTTLE |
FOR TREATMENT OF FOLLOWING BACTERIAL INFECTIONS WHEN CAUSED BY CLARITHROMYCIN- SUSCEPTIBLE BACTERIA: BACTERIAL PHARINGITIS, MILD TO MODERATE COMMUNITY ACQUIRED PNEUMONIA, ACUTE BACTERIAL SINUSITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, SKIN AND SOFT TISSUE INFECTION OF MILD TO MODERATE SEVERITY |
NULL |
LAO INTER PHARMA CO.,LTD |
GETZ PHARMA (PRIVATE) LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 2913/07 |
18-AUG-2023 |
17-AUG-2026 |
View |
| 1469 |
CLARITEK TABLETS 250MG |
CLARITHROMYCIN 250 MG |
FILM-COATED TABLETS |
ALU-ALU BLISTER |
FOR TREATMENT OF FOLLOWING BACTERIAL INFECTIONS WHEN CAUSED BY CLARITHROMYCIN- SUSCEPTIBLE BACTERIA: BACTERIAL PHARINGITIS, MILD TO MODERATE COMMUNITY ACQUIRED PNEUMONIA, ACUTE BACTERIAL SINUSITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, SKIN AND SOFT TISSUE INFECTION OF MILD TO MODERATE SEVERITY |
NULL |
LAO INTER PHARMA CO.,LTD |
GETZ PHARMA (PRIVATE) LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 2916/07 |
18-AUG-2023 |
17-AUG-2026 |
View |
| 1470 |
CLARITEK TABLETS 500MG |
CLARITHROMYCIN 500 MG |
FILM-COATED TABLETS |
ALU-ALU BLISTER |
FOR TREATMENT OF FOLLOWING BACTERIAL INFECTIONS WHEN CAUSED BY CLARITHROMYCIN- SUSCEPTIBLE BACTERIA: BACTERIAL PHARINGITIS, MILD TO MODERATE COMMUNITY ACQUIRED PNEUMONIA, ACUTE BACTERIAL SINUSITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, SKIN AND SOFT TISSUE INFECTION OF MILD TO MODERATE SEVERITY |
NULL |
LAO INTER PHARMA CO.,LTD |
GETZ PHARMA (PRIVATE) LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
04 I 2915/07 |
18-AUG-2023 |
17-AUG-2026 |
View |
